The present invention provides a JNK inhibitor comprising, as an active ingredient, an indazole derivative represented by Formula (I) [wherein R.sup.1 represents substituted or unsubstituted aryl or the like and R.sup.2 represents a hydrogen atom, NR.sup.3R.sup.4 (wherein R.sup.3 and R.sup.4 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkanoyl or the like), carboxy, lower alkenyl or the like] or a pharmaceutically acceptable salt thereof.

 
Web www.patentalert.com

< Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors

< 7-Amido-isoindolyl compounds and methods of their use

> Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors

> Urotensin II receptor agents

~ 00246